ES2290074T3
(es)
|
1993-07-19 |
2008-02-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
ES2151277T3
(es)
*
|
1996-05-22 |
2000-12-16 |
Protarga Inc |
Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
WO1998013359A1
(fr)
*
|
1996-09-24 |
1998-04-02 |
Marigen S.A. |
Ultramicroemulsions constituees de concentres pouvant etre disperses de façon spontanne, renfermant des esters de composes de baccatine-iii a effet antitumoral et antiviral
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
US6649632B2
(en)
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
CA2307393A1
(fr)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Chimiotherapie par administration d'un ginsenoside
|
US20030054036A1
(en)
|
2001-03-13 |
2003-03-20 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
DE60220519T2
(de)
|
2001-04-20 |
2007-09-27 |
The University Of British Columbia, Vancouver |
Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
|
CA2354471A1
(fr)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
Taxanes substitues avec un ester en c10
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
US20040225077A1
(en)
|
2002-12-30 |
2004-11-11 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US20070172446A1
(en)
|
2003-05-16 |
2007-07-26 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
PE20050693A1
(es)
|
2004-02-13 |
2005-09-27 |
Univ Florida State Res Found |
Taxanos sustituidos con esteres de ciclopentilo en c10
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US20060188508A1
(en)
|
2005-02-17 |
2006-08-24 |
Cohen Stanley N |
Methods and compositions for modulating angiogenesis
|
CA2646156C
(fr)
|
2006-03-22 |
2016-05-24 |
Medigene Ag |
Traitement du cancer du sein avec = triple recepteur negatif =
|
WO2008005284A2
(fr)
|
2006-06-30 |
2008-01-10 |
Cook Incorporated |
Procédés de production et de modification de revêtements en taxane destinés à des dispositifs médicaux implantables
|
CA2718567A1
(fr)
|
2008-03-31 |
2009-12-03 |
Florida State University Research Foundation, Inc. |
Taxanes substitues par un ester ethylique en c(10) et un ester cyclopropylique en c(10)
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
WO2009143454A2
(fr)
|
2008-05-22 |
2009-11-26 |
Kereos, Inc. |
Combinaison thérapeutique anticancéreuse
|
WO2010005850A1
(fr)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Procédés et compositions de modulation de l’angiogenèse
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
JP6578206B2
(ja)
|
2012-07-19 |
2019-09-18 |
レッドウッド バイオサイエンス, インコーポレイテッド |
Cd22に特異的な抗体およびその使用方法
|
WO2014074218A1
(fr)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Composés et procédés pour produire un conjugué
|
SI3613439T1
(sl)
|
2013-02-15 |
2021-11-30 |
The Regents Of The University Of California |
Himerni antigenski receptor in postopki njegove uporabe
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
US9493413B2
(en)
|
2013-11-27 |
2016-11-15 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
EP3107899B1
(fr)
|
2014-02-19 |
2020-08-12 |
Aviv Therapeutics, Inc. |
Amides polycycliques se liant à l'aldéhyde déshydrogénase 2 mitochondriale (aldh2) et leur utilisation pour le traitement du cancer
|
US10517961B2
(en)
|
2015-09-25 |
2019-12-31 |
ZY Therapeutics, Inc. |
Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
|
WO2017083637A1
(fr)
|
2015-11-12 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Oligophosphotriesters riches en guanidinium à pénétration cellulaire pour l'administration de médicament et de sonde
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
AU2017257504A1
(en)
|
2016-04-26 |
2018-10-25 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
EP3463308B1
(fr)
|
2016-06-01 |
2021-12-01 |
Servier IP UK Limited |
Formulations d'oxyde de polyalkylène-asparaginase et leurs procédés de fabrication et d'utilisation
|
MX2019008503A
(es)
|
2017-01-18 |
2019-09-13 |
F1 Oncology Inc |
Receptores de antigenos quimericos contra axl o ror2 y metodos de uso de los mismos.
|
EP3388082A1
(fr)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Poly-immunothérapie anticancéreuse avec un complexe de cycle pentaaza macrocyclique
|
CN111902147A
(zh)
|
2018-01-31 |
2020-11-06 |
加莱拉实验室有限责任公司 |
五氮杂大环状环配合物和基于铂的抗癌剂的组合癌症治疗
|
CA3096838A1
(fr)
|
2018-04-11 |
2019-10-17 |
Ohio State Innovation Foundation |
Procedes et compositions pour microparticules a liberation prolongee pour l'administration de medicament oculaire
|
CA3105879A1
(fr)
|
2018-07-18 |
2020-01-23 |
Manzanita Pharmaceuticals, Inc. |
Conjugues pour administrer un agent anticancereux a des cellules nerveuses, methodes d'utilisation et leurs procedes de fabrication
|
WO2020148612A1
(fr)
|
2019-01-14 |
2020-07-23 |
Ignite Immunotherapy, Inc. |
Virus de la vaccine recombinant et ses procédés d'utilisation
|
US11685904B2
(en)
|
2019-02-14 |
2023-06-27 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
CA3131895A1
(fr)
|
2019-04-02 |
2020-10-08 |
Kenjockety Biotechnology, Inc. |
Anticorps multi-specifiques d'un antigene associe a un cancer et d'une pompe d'efflux, ainsi que compositions, reactifs, kits et methodes associes a ceux-ci
|
US20230002740A1
(en)
|
2019-12-12 |
2023-01-05 |
Ignite Immunotherapy, Inc |
Variant oncolytic vaccinia virus and methods of use thereof
|
CN115023443A
(zh)
|
2020-01-29 |
2022-09-06 |
肯乔克蒂生物技术股份有限公司 |
抗mdr1抗体及其用途
|
US20230192902A1
(en)
|
2020-06-04 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
JP2023528416A
(ja)
|
2020-06-04 |
2023-07-04 |
ケンジョッケティ バイオテクノロジー,インク. |
抗abcg2抗体及びそれらの使用
|
KR20230023032A
(ko)
|
2020-07-14 |
2023-02-16 |
화이자 인코포레이티드 |
재조합 백시니아 바이러스
|
WO2022051390A1
(fr)
|
2020-09-02 |
2022-03-10 |
Kenjockety Biotechnology, Inc. |
Anticorps anti-abcc1 et leurs utilisations
|
WO2022103603A1
(fr)
|
2020-11-13 |
2022-05-19 |
Kenjockety Biotechnology, Inc. |
Anticorps anti-mrp4 (codés par le gène abcc4) et leurs utilisations
|
WO2023114658A1
(fr)
|
2021-12-13 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Anticorps anti-abcb1
|
WO2023159220A1
(fr)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anticorps anti-cd47
|